Anatomy of a Breakthrough

Sometimes a doctor changes a patient's life by offering a new therapy when all else fails. Watch Karen's journey with Damon Runyon alum Jedd D. Wolchok, MD, PhD, from when she was diagnosed with melanoma to entering the immunotherapy clinical trial that cured her.

 

 

Our Mission

To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. Since its founding in 1946, Damon Runyon has invested nearly $355 million and funded nearly 3,700 young scientists.

Cooperman

stepping up our drive against cancer

Effective in 2019, the Damon Runyon-Rachleff Innovation and Damon Runyon Clinical Investigator Awards will be increased by 33% for new and current scientists. For 72 years, Damon Runyon has funded the brightest and boldest scientists—risk-takers whose innovative ideas have the potential to make game-changing breakthroughs.

 

 

Yung LieYUNG S. LIE, PHD, NAMED DAMON RUNYON'S NEXT LEADER

Yung S. Lie, PhD, was appointed the incoming President and Chief Executive Officer of the Damon Runyon Cancer Research Foundation. Dr. Lie succeeds Lorraine W. Egan, who will step down in December. Read about Dr. Lie, a former Damon Runyon fellow, as she leads our efforts to end cancer.